Frontline Treatment of Acute Myeloid Leukemia - Episode 10

Management of Cytopenia in Patients on Venetoclax + Azacitidine Therapy

,

Hetty Carraway, MD and Eytan Stein, MD, discuss the appropriate strategies for the management of cytopenias in patients with AML on venetoclax + azacitidine treatment.

EP. 1: Overview of Acute Myeloid Leukemia (AML)
EP. 2: Diagnosis and Cytogenetic Testing in AML
EP. 3: The Goals of Treatment in AML
EP. 4: Frontline Treatment Options for Patients with AML
EP. 5: Intensive Induction Therapy In AML
EP. 6: Treatment Options for Secondary AML
EP. 7: Treatment Options for AML Patients with IDH2, RUNX1, or DNMT3A Mutations
EP. 8: Treatment of Patients Unfit for Intensive Induction with Venetoclax + Azacitidine
EP. 9: Case Presentation: An 81-Year-Old Male with AML
Now Viewing
EP. 10: Management of Cytopenia in Patients on Venetoclax + Azacitidine Therapy
EP. 11: The Importance of Bone Marrow Biopsies in AML Patients on Venetoclax Treatment
EP. 12: Unmet Needs and the Future of AML Treatment